Martina Böhm-Weigert: Supporting Precision Dosing in Hemophilia with Fitusiran
Martina Böhm-Weigert, Scientific Support at Siemens Healthineers, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in RPTH, adding:
“QFITLIA (fitusiran) helps restore hemostasis by lowering antithrombin in individuals with hemophilia A or B, with or without inhibitors.
Maintaining the right therapeutic window is critical.
A recent study published in rpth shows that the INNOVANCE Antithrombin assay can accurately quantify antithrombin activity within the 15 to 35% range required for fitusiran dosing.
With strong precision and no interference from common hemophilia therapies, these data support confident clinical decision making in hemophilia A and B management.”
Title: Analytical validity of the INNOVANCE Antithrombin assay for the measurement of antithrombin activity at fitusiran clinical decision points
Authors: Christoph Freidel, Martina Boehm-Weigert, Christine Dahler, Marek Demissie, Hong Wang, Mingjie Liu, Shariq Ali, Ekta Seth Chhabra
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 22, 2026, 09:15Hasan Abbas Zaheer: How the Future of Thalassaemia Management Can be Made More Equitable and Sustainable
-
Jul 22, 2026, 08:58Hayley Evans: Exploring TXA in Surgery and Its Role in Reducing Blood Loss
-
Jul 22, 2026, 08:56Gijs Aertssen: A Wonderful Conversation on EAHAD’s Meet the Author Podcast
-
Jul 22, 2026, 08:51Toyosi Onwuemene: The Access Gap in Bleeding and Clotting Care
-
Jul 22, 2026, 08:42Rosemary Aikpitanyi-Iduitua: The Remarkable Coordination of Human Blood Physiology
-
Jul 22, 2026, 08:42Christian Heiss: Why Better Models are the Next Frontier in Vascular Ageing
-
Jul 22, 2026, 08:35Exploring Haemophilia B With Inhibitors at EHC ERIN
-
Jul 22, 2026, 08:13How Long Does It Really Take to Recover from a Joint Bleed – EAHAD
-
Jul 22, 2026, 05:26Richard Dalyai: Can AI Safely Refill Medications?